| ID | 56873 | 
| JaLCDOI | |
| FullText URL | |
| Author | 
                Makimoto, Go
                Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
     
                Nishimori, Hisakazu
                Department of Hematology and Oncology, Okayama University Hospital
     
                Kondo, Reiko
                Okayama University Medical School
     
                Yanai, Hiroyuki
                Department of Pathology, Okayama University Hospital
     
                Sugimoto, Morito
                Department of Urology, Okayama University Hospital
     
                Oda, Naohiro
                Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
     
                Kubo, Toshio
                Center for Clinical Oncology, Okayama University Hospital
     
                Hotta, Katsuyuki
                Center of Innovative Clinical Medicine, Okayama University Hospital
     
                Tabata, Masahiro
                Center for Clinical Oncology, Okayama University Hospital
     
                Kiura, Katsuyuki
                Department of Allergy and Respiratory Medicine, Okayama University Hospital
     
                Maeda, Yoshinobu
                Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
     | 
| Abstract |  Urothelial carcinoma usually presents with hematuria, but cases of multiple lymphadenopathy with elevated S-pancreas-1 antigen (SPan-1) levels have not been reported. A 62-year-old Japanese man with lymphadenopathies was diagnosed with an adenocarcinoma of unknown origin and transferred to our hospital for further diagnosis. Serum carbohydrate antigen 19-9 and SPan-1 levels were extremely elevated. Uroplakin III immunostaining was positive in the inguinal lymph node, and cystoscopy revealed the presence of invasive urothelial carcinoma. Treatment with cisplatin and gemcitabine promoted a complete metabolic response for > 4 years. The detection of uroplakin III and serum SPan-1 might help diagnose urothelial carcinoma. | 
| Keywords | urothelial carcinoma uroplakin III s-pancreas-1 antigen carbohydrate antigen 19-9 chemotherapy | 
| Amo Type | Case Report | 
| Publication Title | 
            Acta Medica Okayama
     | 
| Published Date | 2019-06 | 
| Volume | volume73 | 
| Issue | issue3 | 
| Publisher | Okayama University Medical School | 
| Start Page | 279 | 
| End Page | 284 | 
| ISSN | 0386-300X | 
| NCID | AA00508441 | 
| Content Type | 
            Journal Article
     | 
| language | 
            English
     | 
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School | 
| File Version | publisher | 
| Refereed | 
            True
     | 
| PubMed ID |